Search

Your search keyword '"Mazzone E"' showing total 1,046 results

Search Constraints

Start Over You searched for: Author "Mazzone E" Remove constraint Author: "Mazzone E"
1,046 results on '"Mazzone E"'

Search Results

3. Which is the optimal multimodal management of pN1 patients with PSA persistence after radical prostatectomy and extended nodal dissection? Results of a large, multi-institutional database

4. PSA doubling time thresholds in predicting clinical recurrence after biochemical recurrence in surgically treated prostate cancer patients. The Impact of nodal status and adjuvant radiotherapy

5. Does the accuracy of PSA density change according to prostate volume? Assessing the diagnostic accuracy at the extreme values of prostate volume in a large single institution series

6. The quantification of GSP4 volume is superior to ISUP GG classification and %GSP4 for predicting adverse outcomes in radical prostatectomy patients

7. Assessing epigenetic features associated with lymph node metastases in prostate cancer

8. Age-dependent effect of early salvage radiotherapy for biochemical recurrence in prostate cancer patients treated with radical prostatectomy

9. PSMA radio-guided surgery to detect nodal metastases in prostate cancer patients undergoing robot-assisted radical prostatectomy and extended pelvic lymph node dissection: Updated results of a planned interim analysis of a prospective phase 2 study

11. Identifying the optimal definition of PSA response after metastasis directed therapy in men with oligo-recurrent prostate cancer detected at PSMA PET

12. Clinical characteristics of patients with renal cancer do impact more than ischemia time on post-operative renal function

13. Train the trainers for the delivery of proficiency based progression training by the european robotic surgical section fellowship centers

14. Long-term oncological outcomes of surgically managed very high-risk prostate cancer patients according to the STAMPEDE trial definition: Implications for the selection of candidates for clinical trials

15. Validation of the EAU risk groups for radical prostatectomy prostate cancer patients who experienced biochemical recurrence restaged with PSMA PET imaging and development of a novel tool

16. A novel PRECISE implemented predictive model to assess the risk of long-term disease reclassification in men on active surveillance. Results from a large, single institution series

17. The role of artificial intelligence for the detection of clinically significant prostate cancer at multiparametric magnetic resonance imaging

18. Optimizing the number of systematic cores during MRI target biopsy. Preliminary results from the prospective, paired-cohort SCOT Trial

19. Effect of Metastasis Directed Therapy (MDT) in men with PSMA PET detected recurrent prostate cancer according to time from primary treatment. Do men with late recurrences really benefit from MDT? Results from a large, single institution series

20. The importance of high volume providers in the diagnostic pathways of prostate cancer. Results from large, singe Institution series

21. Towards a tailored use of PSA density to decide when to avoid prostate biopsy in men with PIRADS 3 lesions according to the location of the index lesion at mp-MRI. Results of a large, multi-institutional series

22. How can we reduce the rates of false positive findings at mpMRI? The pivotal role of urologist expertise assessed in a large, single center series

24. Gain and loss of upper limb abilities in Duchenne muscular dystrophy patients: A 24-month study

26. Prediction of large‐for‐gestational age at 36 weeks' gestation: two‐dimensional ultrasound vs three‐dimensional ultrasound vs magnetic resonance imaging.

27. Delphi Consensus Project on Prostate-specific Membrane Antigen (PSMA)-Targeted Surgery – outcomes from an international multidisciplinary panel

30. The IRON Study: Investigation of Robot-assisted Versus Open Nephron-sparing Surgery

31. Proficiency‐based progression training for robotic surgery skills training: a randomized clinical trial

32. Patient reported outcome measure for upper limb in Duchenne muscular dystrophy: correlation with PUL2.0

33. Categorizing natural history trajectories of ambulatory function measured by the 6-minute walk distance in patients with Duchenne muscular dystrophy

36. When is central histological review of prostate biopsy really needed to reduce the risk of misclassification of prostate cancer? The importance of patient risk stratification

37. Oncologic outcomes of patients with incidental prostate cancer: Can we rely on multiparametric mri to exclude aggressive prostate cancer?

38. Is there an impact of the center performing baseline multiparametric MRI on active surveillance outcomes in prostate cancer patients?

39. Tailoring the optimal use of androgen-deprivation therapy concomitant to post-operative radiotherapy among men with pN1 prostate cancer. Long-term results of a large, single Institution series

40. Can we predict the site of positive surgical margins based on the site of the index lesion at multiparametric mri? A topographic, single center study

41. Added value of mpmri in the stratification of patients with high-risk patients prostate cancer treated with radical prostatectomy: implications for tailored multi-modal strategies

42. Does a positive multi-parametric MRI always warrant prostate biopsy? the importance of integrating clinical and imaging data based on a large, multi-institutional series

43. Development and validation of a novel nomogram predicting long-term progression in patients treated with early salvage radiation therapy after radical prostatectomy: the key role of PSA kinetics

44. Long-term oncologic outcomes of robot-assisted radical cystectomy: Update series from an high-volume robotic center beyond 10 years of follow-up

45. Does previous prostatic surgery affect the accuracy of multiparametric MRI in detecting clinically significant prostate cancer? Results from a single center, high volume series

46. The impact of cumulative smoking status on perioperative morbidity after robot-assisted radical cystectomy

47. How to optimize patient selection before salvage lymph node dissection for nodal recurrent prostate cancer: a novel risk stratification tool

48. 99M-technetium-psma radio-guided surgery to detect nodal metastases in prostate cancer patients undergoing radical prostatectomy and extended pelvic lymph node dissection: a phase 2 prospective, single-institution study

49. The risk of recurrence in cN1 prostate cancer patients treated with radical prostatectomy varies according to the type preoperative staging. a comparison between 68ga-PSMA-PET versus conventional imaging in a large, multi-institutional study

50. A more extended pelvic lymph node dissection decreases recurrence rates in selected prostate cancer patients undergoing radical prostatectomy

Catalog

Books, media, physical & digital resources